EIF4A2P5: A Potential Drug Target and Biomarker (G106480446)

Target Name: EIF4A2P5

NCBI ID: G106480446

EIF4A2P5

Other Name(s): Eukaryotic translation initiation factor 4A2 pseudogene 5 | eukaryotic translation initiation factor 4A2 pseudogene 5

EIF4A2P5: A Potential Drug Target and Biomarker

Eukaryotic translation initiation factor 4A2 pseudogene 5 (EIF4A2P5) is a protein that plays a crucial role in the process of translation of RNA into protein in eukaryotic cells. It is a key regulator of the initiation of the translation process, and its function is essential for the proper functioning of the cell.

Recent studies have identified EIF4A2P5 as a potential drug target and biomarker for various diseases, including cancer, neurodegenerative diseases, and respiratory disorders. This is due to its involvement in the regulation of translation, which is a key process in the development and progression of many diseases.

One of the key reasons for the potential of EIF4A2P5 as a drug target is its involvement in the regulation of cancer progression. Many cancer cells are able to bypass the normal translation process and continue to grow and multiply uncontrollably. EIF4A2P5 is involved in the regulation of this process, and studies have shown that it can be a useful target for cancer therapies.

Another potential drug target for EIF4A2P5 is its role in the regulation of neurodegenerative diseases. As neurodegenerative diseases such as Alzheimer's and Parkinson's disease progress, the normal functioning of the brain is affected, and the translation process is often disrupted. EIF4A2P5 plays a key role in the regulation of this process, and studies have shown that targeting it may be a promising approach to treating neurodegenerative diseases.

In addition to its potential as a drug target, EIF4A2P5 has also been identified as a potential biomarker for various diseases. Its involvement in the regulation of translation makes it an attractive candidate for use as a diagnostic marker for diseases that affect the translation process. For example, studies have shown that EIF4A2P5 levels can be affected by a variety of factors, including stress, exercise, and certain medications. This may make it a useful biomarker for tracking the effects of these treatments on the translation process.

Another potential application of EIF4A2P5 as a drug target is its role in the regulation of respiratory disorders. Many respiratory disorders are caused by problems with the translation process, such as those caused by genetic mutations. EIF4A2P5 plays a key role in the regulation of this process, and studies have shown that targeting it may be a promising approach to treating respiratory disorders.

In conclusion, EIF4A2P5 is a protein that plays a crucial role in the regulation of translation in eukaryotic cells. Its involvement in the development and progression of many diseases makes it a potential drug target and biomarker. Further research is needed to fully understand its role in these processes and to develop effective treatments.

Protein Name: Eukaryotic Translation Initiation Factor 4A2 Pseudogene 5

The "EIF4A2P5 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about EIF4A2P5 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets